ibrutinib
janssen,abbvie
['ibru', 'cll']
glad to hear that cll12 confirmed watch and wait as a plausible option compared to ibrutinib in early stage cll. no os benefit!! 
UT Health San Antonio - Mays Cancer Center.  Hematologist-Oncologist with focus on Lymphomas and Health Care Disparities.  Views are my own